Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SGLT2 Inhibitors in Kidney Diseases—A Narrative Review
Agata Gajewska, Jakub Wasiak, Natalia Sapeda, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4959-4959
Open Access | Times Cited: 9

Showing 9 citing articles:

Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access | Times Cited: 1
Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management—A Narrative Review
Ewelina Młynarska, Jakub Wasiak, Agata Gajewska, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1938-1938
Open Access | Times Cited: 8
mCNN-glucose: Identifying families of glucose transporters using a deep convolutional neural network based on multiple-scanning windows
Syed Muazzam Ali Shah, Muhammad Rafi, Muhammad Shahid Malik, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139522-139522
Closed Access
Update on the Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibitors in Patients with Chronic Diseases: A Systematic Review and Meta-Analysis
I-Chia Liang, Hsun-Hao Chang, Yu-Jou Lai, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 202-202
Open Access
Short-term effects of empagliflozin on preventing contrast induced acute kidney injury in patients undergoing percutaneous coronary intervention, a randomised trial
Zeinab Hosseini, Mohammad Javad Jamili, Behzad Ensan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Incretins and SGLT-2 inhibitors in diabetic patients with neuroendocrine tumors: current updates and future directions
Rosaria Maddalena Ruggeri, Erika Grossrubatscher, Eleonora Ciocca, et al.
Reviews in Endocrine and Metabolic Disorders (2025)
Open Access
Update in non-alcoholic fatty liver disease management: role of sodium-glucose cotransporter 2 inhibitors
Oscar René Zambrano-Vásquez, Fernando Cortés-Camacho, Jorge Ismael Castañeda‐Sánchez, et al.
Life Sciences (2025), pp. 123638-123638
Closed Access
Microbiota and Diabetes: Decoding the Gut-Metabolism Link in a Single-Center Study
Nicoleta Mihaela Mindrescu, Cristian Guja, Viorel Jinga, et al.
Gastrointestinal Disorders (2025) Vol. 7, Iss. 2, pp. 32-32
Open Access
Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1)
Ashot Avagimyan, Mohammad Sheibani, А. И. Трофименко, et al.
Innovative medicine of Kuban (2024), Iss. 4, pp. 126-135
Open Access | Times Cited: 1
Omics Studies in CKD: Diagnostic Opportunities and Therapeutic Potential
Merita Rroji, Goce Spasovski
PROTEOMICS (2024)
Closed Access
Page 1

Scroll to top